Shl Medical
Shl Medical, a leading name in the medical device industry, is headquartered in Switzerland (CH) and operates extensively across Europe and North America. Founded in 1985, the company has established itself as a pioneer in the development and manufacturing of innovative drug delivery systems, particularly in the fields of injectable devices and auto-injectors. Shl Medical's core offerings include advanced pen injectors and wearable delivery systems, distinguished by their user-centric design and precision engineering. With a commitment to quality and safety, the company has achieved significant milestones, including ISO certifications and partnerships with major pharmaceutical firms. Recognised for its expertise and reliability, Shl Medical continues to strengthen its market position, contributing to improved patient outcomes worldwide.
DitchCarbon Score
How does Shl Medical's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Shl Medical's score of 41 is higher than 98% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Shl Medical's reported carbon emissions
In 2023, SHL Medical reported total carbon emissions of approximately 290,355,000 kg CO2e, a slight decrease from about 298,110,000 kg CO2e in 2022. The emissions breakdown for 2023 includes approximately 43,271,000 kg CO2e from Scope 1, 440,000 kg CO2e from Scope 2, and about 246,644,000 kg CO2e from Scope 3 emissions. Notably, the largest contributors to Scope 3 emissions were purchased goods and services (approximately 125,723,000 kg CO2e) and employee commuting (about 10,655,000 kg CO2e). SHL Medical has set ambitious climate commitments, aiming to reduce absolute Scope 1 and 2 greenhouse gas emissions by 42% by 2030, using 2022 as the base year. Additionally, the company targets a 51.6% reduction in Scope 3 emissions related to purchased goods and services, employee commuting, and downstream transportation and distribution per million units sold within the same timeframe. These targets align with the Science Based Targets initiative (SBTi) and are consistent with efforts to limit global warming to 1.5°C.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2022 | 2023 | |
|---|---|---|
| Scope 1 | 42,973,000 | 00,000,000 |
| Scope 2 | 633,000 | 000,000 |
| Scope 3 | 254,504,000 | 000,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Shl Medical is committed to some reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
